# Century Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/century-genomics

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: http://www.ome.health
- Total disclosed funding: $0.9M
- Latest round: Seed (Jan 9, 2018)
- Investors on record: 3

## About

Century Genomics Limited is a health technology company that operates a platform for personalized health coaching, providing clients with tailored nutrition recommendations and comprehensive practice management tools.Founded in 2016 and headquartered in London, UK, Century Genomics Limited focuses on offering a health coaching platform that supports personalized client health management. The company was co-founded by Aidas Pranculis and Karolis Rosickas, with Pranculis also serving as the CEO. In January 2018, Century Genomics raised GBP 700 thousand in SEED funding from investors including Inventure, Döhler Ventures, and Practica Capital, bringing the total amount raised to GBP 700 thousand and the post-money company valuation to GBP 3.57 million.OME Health operates a health coaching platform that emphasizes client health support and practice management. Its offerings include personalized nutrition recommendations, progress tracking through smart device data, and access to an extensive recipe database featuring over 10,000 meals tailored to individual health needs. This platform is aimed at health professionals, clients, and business partners, facilitating the automation of routine tasks and enhancing client engagement through features like goal setting, food logging, and in-app communication. OME Health serves a diverse clientele, including health coaches and nutritionists, primarily targeting markets in North America and Europe.OME Health generates revenue through a profit-sharing model based on subscription sales, supplements, tests, and consultations provided to clients. Health professionals can access the platform without charge while earning commissions from sales made through their unique referral codes. The company operates primarily on a B2B model, catering to health coaches who deliver services directly to consumers. Revenue is further enhanced by subscription plans offering tailored nutrition services and products, with a user-friendly one-click checkout process for consultations and supplements, streamlining transactions for both practitioners and clients.Century Genomics Limited aims to utilize the GBP 700 thousand raised in the SEED funding round on January 9, 2018, to support ongoing product development and expansion efforts. Future strategies include launching new features and enhancements on the health coaching platform, as well as exploring entry into additional markets in Europe and North America by 2025, in response to increasing demand for personalized health solutions.

## Funding rounds

- Seed, Jan 9, 2018, $0.9M — Inventure, Practica Capital, Doehler Ventures

## Investors

- Inventure (https://capitalatlas.ai/funds/inventure) — Seed
- Practica Capital (https://capitalatlas.ai/funds/practica-capital) — Seed
- Doehler Ventures (https://capitalatlas.ai/funds/doehler-ventures) — Seed